Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Financial Flexibility Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥95.40 Million (operating CF CN¥-12.88 Million minus capex CN¥108.28 Million) represents 0% of total liabilities (CN¥676.07 Million). Check 301263 financial resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. See Guangdong Taienkang Pharmaceutical Co. L current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see Guangdong Taienkang Pharmaceutical Co. L market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥95.40 Million | CN¥-12.88 Million | CN¥676.07 Million | ▼ -55.8% |
| 2024 | 0.32x | CN¥157.88 Million | CN¥89.33 Million | CN¥494.67 Million | ▼ -56.5% |
| 2023 | 0.73x | CN¥293.53 Million | CN¥93.53 Million | CN¥399.72 Million | ▼ -42.9% |
| 2022 | 1.29x | CN¥238.69 Million | CN¥148.81 Million | CN¥185.63 Million | ▲ +80.9% |
| 2021 | 0.71x | CN¥164.67 Million | CN¥120.02 Million | CN¥231.71 Million | ▼ -20.3% |
| 2020 | 0.89x | CN¥218.65 Million | CN¥125.53 Million | CN¥245.12 Million | ▲ +91.7% |
| 2019 | 0.47x | CN¥84.27 Million | CN¥75.44 Million | CN¥181.16 Million | — |